Literature DB >> 12364869

Mechanism of T cell-mediated endothelial apoptosis.

Alexander S Krupnick1, Daniel Kreisel, Sicco H Popma, Keki R Balsara, Wilson Y Szeto, Alyssa M Krasinskas, Markus Riha, Andrew D Wells, Laurence A Turka, Bruce R Rosengard.   

Abstract

BACKGROUND: Cytotoxic T lymphocyte (CTL)-mediated destruction of allogeneic vascular endothelium is important in the pathogenesis of both acute and chronic allograft rejection. Despite the importance of this phenomenon, the effector mechanisms responsible for endothelial cell killing are not well defined, and conflicting conclusions have been reached based on variation in experimental methodology.
METHODS: We used a recently described method for isolating mouse vascular endothelium to evaluate endothelial cell lysis by CTLs. Endothelial cell destruction was assessed in vitro both by 51Cr release and DNA fragmentation using wild-type and lpr (Fas deficient) endothelium of C3H/HeJ (H2(k)) mice by MHC alloantigen-specific T cells of wild-type, gld (Fas ligand deficient), and perforin-deficient mice on a C57BL/6 (H2(b)) background.
RESULTS: Although maximal lysis of 56.6+/-0.8% was seen when using wild-type targets and effectors, only a moderate decrease in apoptosis to 37.6+/-4.0% was detected when the Fas/Fas ligand death receptor pathway was eliminated. This decrease in cytotoxicity occurred despite the preserved functional capacity of this pathway. Alternatively, a significant decrease in cytotoxicity to 17.4+/-4.7% was seen when the perforin/granzyme exocytosis pathway was eliminated.
CONCLUSIONS: These data indicate that CTLs destroy vascular endothelium primarily by the perforin/granzyme exocytosis pathway with only a minor contribution to apoptosis by the Fas/Fas ligand death receptor pathway. These data are critical for the proper interpretation of studies evaluating acute and chronic allograft rejection and for the design of rational strategies to ameliorate vascular injury concomitant to the rejection process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364869     DOI: 10.1097/00007890-200209270-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens.

Authors:  Xi Zhao; Anamika Bose; Hideo Komita; Jennifer L Taylor; Mayumi Kawabe; Nina Chi; Laima Spokas; Devin B Lowe; Christina Goldbach; Sean Alber; Simon C Watkins; Lisa H Butterfield; Pawel Kalinski; John M Kirkwood; Walter J Storkus
Journal:  Mol Ther       Date:  2010-12-28       Impact factor: 11.454

Review 2.  Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?

Authors:  Muna Affara; Benjamin Dunmore; Christopher Savoie; Seiya Imoto; Yoshinori Tamada; Hiromitsu Araki; D Stephen Charnock-Jones; Satoru Miyano; Cristin Print
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

3.  Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.

Authors:  Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

4.  Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity.

Authors:  Patricia L Judson; Entidhar Al Sawah; Douglas C Marchion; Yin Xiong; Elona Bicaku; Nadim Bou Zgheib; Hye Sook Chon; Xiaomang B Stickles; Ardeshir Hakam; Robert M Wenham; Sachin M Apte; Jesus Gonzalez-Bosquet; Dung-Tsa Chen; Johnathan M Lancaster
Journal:  Int J Gynecol Cancer       Date:  2012-07       Impact factor: 3.437

5.  Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantation.

Authors:  A Mohammed; O Ulukpo; E C Lawrence; F Fernandez; A Pickens; A A Gal; S D Force; K C Easley; C P Larsen; A D Kirk; D C Neujahr
Journal:  Transplant Proc       Date:  2011-12       Impact factor: 1.066

6.  Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy.

Authors:  Chelsey L King; Jennifer J Devitt; Timothy D G Lee; Camille L Hancock Friesen
Journal:  J Cardiothorac Surg       Date:  2010-06-22       Impact factor: 1.637

7.  Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.

Authors:  Jonathan C Choy; Alexandra Kerjner; Brian W Wong; Bruce M McManus; David J Granville
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

8.  Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.

Authors:  Luis J Espinoza; Akiyoshi Takami; Katsuya Nakata; Kayoko Yamada; Makoto Onizuka; Takakazu Kawase; Hiroshi Sao; Hideki Akiyama; Koichi Miyamura; Shinichiro Okamoto; Masami Inoue; Takahiro Fukuda; Yasuo Morishima; Yoshihisa Kodera; Shinji Nakao
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

Review 9.  Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis.

Authors:  Anna von Rossum; Ismail Laher; Jonathan C Choy
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

Review 10.  Advanced in vitro Research Models to Study the Role of Endothelial Cells in Solid Organ Transplantation.

Authors:  Daphne M Peelen; Martin J Hoogduijn; Dennis A Hesselink; Carla C Baan
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.